8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Published . Updated .
Key takeaways
- 8-K - ONCOLYTICS BIOTECH filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
- Exposed: ONCY
- Market reaction: ONCY +0.9% on the day (still updating)
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - ONCOLYTICS BIOTECH filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
Directly affected
- ONCY Oncolytics Biotech-10.8% 19d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.
- LLY Eli Lilly and+14.3% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- JNJ Johnson & Johnson+3.3% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- PFE Pfizer+2.3% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- MRK Merck+3.4% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ONCY | -9.61% | -2.44% | base | +0.87% | after close | after close | after close |
| XLV | -0.10% | +2.63% | base | after close | after close | after close | after close |
| XBI | -0.10% | +4.53% | base | +0.12% | after close | after close | after close |
| LLY | +4.21% | +4.67% | base | after close | after close | after close | after close |
| JNJ | -2.08% | +0.00% | base | after close | after close | after close | after close |
| PFE | +4.51% | +4.78% | base | after close | after close | after close | after close |
| MRK | +1.15% | +2.46% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-09 AccNo: 0001129928-26-000080 Size: 162 KB Item 8.01: Other Events
Source: sec-edgar
Oncolytics Biotech (ONCY)
Across 5 earlier stories, Oncolytics Biotech (ONCY) the next day averaged +7.79%. The largest gain was +15.60% and the largest drop was -6.28%, from 5 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Oncolytics Biotech (ONCY) | the next day | +7.79% | +15.60% | -6.28% | 5 |
| Oncolytics Biotech (ONCY) | three days later | -0.24% | +5.76% | -9.28% | 4 |
How far Oncolytics Biotech (ONCY) has moved since 9 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | three days earlier | 0.00% | final price |
| JNJ | five days earlier | -2.08% | final price |
| LLY | three days earlier | +4.67% | final price |
| LLY | five days earlier | +4.21% | final price |
| MRK | three days earlier | +2.46% | final price |
| MRK | five days earlier | +1.15% | final price |
| Oncolytics Biotech (ONCY) | that day | +0.87% | still updating |
| Oncolytics Biotech (ONCY) | three days earlier | -2.44% | final price |
| Oncolytics Biotech (ONCY) | five days earlier | -9.61% | final price |
| PFE | three days earlier | +4.78% | final price |
| PFE | five days earlier | +4.51% | final price |
| XBI | that day | +0.12% | still updating |
| XBI | three days earlier | +4.53% | final price |
| XBI | five days earlier | -0.10% | final price |
| XLV | three days earlier | +2.63% | final price |
| XLV | five days earlier | -0.10% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 40 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 45 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 62 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 80 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 82 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)”
Companies tied to this story
- ONCY Oncolytics Biotech
Oncolytics Biotech (ONCY) is linked, with no stored direction, high confidence in the 9 Nov 2026 story “8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ONCY
How “8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)” reaches Oncolytics Biotech (ONCY)
“8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)” (9 Nov 2026) reaches Oncolytics Biotech (ONCY) through this story.
The link for Oncolytics Biotech (ONCY) is this: SEC 8-K filing -> direct issuer disclosure -> ONCY
Dates in the story, and the Oncolytics Biotech (ONCY) price range
ONCY traded between 0.38 and 0.58 across 19 sessions. The latest close on file is 0.44.
A simple score for Oncolytics Biotech (ONCY)
14 out of 100Price not final
“8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.